177 related articles for article (PubMed ID: 8094831)
1. Persistence of initial infection in recurrent Cryptococcus neoformans meningitis.
Spitzer ED; Spitzer SG; Freundlich LF; Casadevall A
Lancet; 1993 Mar; 341(8845):595-6. PubMed ID: 8094831
[TBL] [Abstract][Full Text] [Related]
2. Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients.
Pfaller M; Zhang J; Messer S; Tumberland M; Mbidde E; Jessup C; Ghannoum M
Diagn Microbiol Infect Dis; 1998 Nov; 32(3):191-9. PubMed ID: 9884835
[TBL] [Abstract][Full Text] [Related]
3. Rapid relapse of cryptococcal meningitis after termination of maintenance fluconazole in AIDS.
Haglund LA; Greenfield RA
Am J Med; 1992 Apr; 92(4):449-50. PubMed ID: 1558095
[No Abstract] [Full Text] [Related]
4. Cryptococcal meningitis associated with acquired immunodeficiency syndrome (AIDS) in African patients: treatment with fluconazole.
Laroche R; Dupont B; Touze JE; Taelman H; Bogaerts J; Kadio A; M'Pele P; Latif A; Aubry P; Durbec JP
J Med Vet Mycol; 1992; 30(1):71-8. PubMed ID: 1573523
[TBL] [Abstract][Full Text] [Related]
5. Cryptoccocal meningitis in Yaoundé (Cameroon) HIV infected patients: Diagnosis, frequency and Cryptococcus neoformans isolates susceptibility study to fluconazole.
Kammalac Ngouana T; Dongtsa J; Kouanfack C; Tonfack C; Fomena S; Mallié M; Delaporte E; Boyom FF; Bertout S
J Mycol Med; 2015 Mar; 25(1):11-6. PubMed ID: 25467817
[TBL] [Abstract][Full Text] [Related]
6. Parenteral and oral fluconazole for acute cryptococcal meningitis in AIDS: experience with thirteen patients.
Stern JJ; Pietroski NA; Buckley RM; Braffman MN; Rinaldi MG
Ann Pharmacother; 1992; 26(7-8):876-82. PubMed ID: 1504391
[TBL] [Abstract][Full Text] [Related]
7. Persistence, replacement, and microevolution of Cryptococcus neoformans strains in recurrent meningitis in AIDS patients.
Sullivan D; Haynes K; Moran G; Shanley D; Coleman D
J Clin Microbiol; 1996 Jul; 34(7):1739-44. PubMed ID: 8784580
[TBL] [Abstract][Full Text] [Related]
8. Genotyping and antifungal susceptibility testing of Cryptococcus neoformans isolates from Cameroonian HIV-positive adult patients.
Bertout S; Drakulovski P; Kouanfack C; Krasteva D; Ngouana T; Dunyach-Rémy C; Dongtsa J; Aghokeng A; Delaporte E; Koulla-Shiro S; Reynes J; Mallié M
Clin Microbiol Infect; 2013 Aug; 19(8):763-9. PubMed ID: 23033854
[TBL] [Abstract][Full Text] [Related]
9. Cryptococcal ventricular-peritoneal shunt infection: clinical and epidemiological evaluation of two closely associated cases.
Ingram CW; Haywood HB; Morris VM; Allen RL; Perfect JR
Infect Control Hosp Epidemiol; 1993 Dec; 14(12):719-22. PubMed ID: 8132998
[TBL] [Abstract][Full Text] [Related]
10. [Cryptococcosis caused by Cryptococcus neoformans var. Gattii. A case associated with acquired immunodeficiency syndrome (AIDS) in Kinshasa, Zaire].
Muyembe Tamfum JJ; Mupapa Kibadi D; Nganda L; Ngwala-Bikindu D; Kuezina T; Kela-We I; Vandepitte J
Med Trop (Mars); 1992; 52(4):435-8. PubMed ID: 1494313
[TBL] [Abstract][Full Text] [Related]
11. Clinical and laboratory features of cryptococcal meningitis in HIV-AIDS patients.
Deo S
J Assoc Physicians India; 1995 Oct; 43(10):724. PubMed ID: 8773019
[No Abstract] [Full Text] [Related]
12. Karyotyping of Cryptococcus neoformans as an epidemiological tool.
Perfect JR; Ketabchi N; Cox GM; Ingram CW; Beiser CL
J Clin Microbiol; 1993 Dec; 31(12):3305-9. PubMed ID: 8308124
[TBL] [Abstract][Full Text] [Related]
13. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
Manosuthi W; Sungkanuparph S; Thongyen S; Chumpathat N; Eampokalap B; Thawornwan U; Foongladda S
J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
[TBL] [Abstract][Full Text] [Related]
14. [Molecular characterization of Cryptococcus neoformans isolates from HIV patients, Guayaquil, Ecuador].
Sánchez S; Zambrano D; García M; Bedoya C; Fernández C; Illnait-Zaragozí MT
Biomedica; 2017 Sep; 37(3):425-430. PubMed ID: 28968020
[TBL] [Abstract][Full Text] [Related]
15. Increased fluconazole resistance of Cryptococcus neoformans isolated from a patient with AIDS and recurrent meningitis.
Paugam A; Dupouy-Camet J; Blanche P; Gangneux JP; Tourte-Schaefer C; Sicard D
Clin Infect Dis; 1994 Nov; 19(5):975-6. PubMed ID: 7893896
[No Abstract] [Full Text] [Related]
16. Cryptococcus neoformans var. gattii meningitis in Egypt: a case report.
Mansour A; Nakhla I; El Sherif M; Sultan YA; Frenck RW
East Mediterr Health J; 2006; 12(1-2):241-4. PubMed ID: 17037245
[No Abstract] [Full Text] [Related]
17. Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS.
Jaruratanasirikul S
Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):719-23. PubMed ID: 9253873
[TBL] [Abstract][Full Text] [Related]
18. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.
Powderly WG; Saag MS; Cloud GA; Robinson P; Meyer RD; Jacobson JM; Graybill JR; Sugar AM; McAuliffe VJ; Follansbee SE
N Engl J Med; 1992 Mar; 326(12):793-8. PubMed ID: 1538722
[TBL] [Abstract][Full Text] [Related]
19. Cryptococcus tetragattii as a major cause of cryptococcal meningitis among HIV-infected individuals in Harare, Zimbabwe.
Nyazika TK; Hagen F; Meis JF; Robertson VJ
J Infect; 2016 Jun; 72(6):745-752. PubMed ID: 27038502
[TBL] [Abstract][Full Text] [Related]
20. Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain.
Gago S; Serrano C; Alastruey-Izquierdo A; Cuesta I; Martín-Mazuelos E; Aller AI; Gómez-López A; Mellado E
Mycoses; 2017 Jan; 60(1):40-50. PubMed ID: 27633849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
